155 related articles for article (PubMed ID: 31986311)
21. Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.
Budzyńska PM; Kyläniemi MK; Kallonen T; Soikkeli AI; Nera KP; Lassila O; Alinikula J
Eur J Immunol; 2017 Jun; 47(6):993-1001. PubMed ID: 28301039
[TBL] [Abstract][Full Text] [Related]
22. AID preferentially targets the top strand in nucleosome sequences.
Singh AK; Jaiswal A; Kodgire P
Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
[TBL] [Abstract][Full Text] [Related]
23. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
25. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.
Pradeepa MM; Sutherland HG; Ule J; Grimes GR; Bickmore WA
PLoS Genet; 2012; 8(5):e1002717. PubMed ID: 22615581
[TBL] [Abstract][Full Text] [Related]
26. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
27. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
[TBL] [Abstract][Full Text] [Related]
28. Histone modifications associated with somatic hypermutation.
Odegard VH; Kim ST; Anderson SM; Shlomchik MJ; Schatz DG
Immunity; 2005 Jul; 23(1):101-10. PubMed ID: 16039583
[TBL] [Abstract][Full Text] [Related]
29. High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes.
Goebel P; Montalbano A; Ayers N; Kompfner E; Dickinson L; Webb CF; Feeney AJ
J Immunol; 2002 Sep; 169(5):2477-87. PubMed ID: 12193717
[TBL] [Abstract][Full Text] [Related]
30. Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion.
Kitao H; Kimura M; Yamamoto K; Seo H; Namikoshi K; Agata Y; Ohta K; Takata M
Int Immunol; 2008 Feb; 20(2):277-84. PubMed ID: 18182382
[TBL] [Abstract][Full Text] [Related]
31. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
32. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation.
Chatterji M; Unniraman S; McBride KM; Schatz DG
J Immunol; 2007 Oct; 179(8):5274-80. PubMed ID: 17911613
[TBL] [Abstract][Full Text] [Related]
33. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
[TBL] [Abstract][Full Text] [Related]
34. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
Pan-Hammarström Q; Dai S; Zhao Y; van Dijk-Härd IF; Gatti RA; Børresen-Dale AL; Hammarström L
J Immunol; 2003 Apr; 170(7):3707-16. PubMed ID: 12646636
[TBL] [Abstract][Full Text] [Related]
35. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
36. Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Craigie M; Regan P; Otalora YL; Sariyer IK
Virol J; 2015 Nov; 12():196. PubMed ID: 26596376
[TBL] [Abstract][Full Text] [Related]
37. Somatic hypermutation of the AID transgene in B and non-B cells.
Martin A; Scharff MD
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein.
Aksaas AK; Eikvar S; Akusjärvi G; Skålhegg BS; Kvissel AK
Genes Cancer; 2011 Aug; 2(8):841-51. PubMed ID: 22393468
[TBL] [Abstract][Full Text] [Related]
39. Restriction of AID activity and somatic hypermutation by PARP-1.
Tepper S; Mortusewicz O; Członka E; Bello A; Schmidt A; Jeschke J; Fischbach A; Pfeil I; Petersen-Mahrt SK; Mangerich A; Helleday T; Leonhardt H; Jungnickel B
Nucleic Acids Res; 2019 Aug; 47(14):7418-7429. PubMed ID: 31127309
[TBL] [Abstract][Full Text] [Related]
40. Ubinuclein-1 confers histone H3.3-specific-binding by the HIRA histone chaperone complex.
Ricketts MD; Frederick B; Hoff H; Tang Y; Schultz DC; Singh Rai T; Grazia Vizioli M; Adams PD; Marmorstein R
Nat Commun; 2015 Jul; 6():7711. PubMed ID: 26159857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
